Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
380 participants
INTERVENTIONAL
1999-07-31
2005-01-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will test the following hypotheses regarding the effectiveness of early paraprofessional home visiting for at-risk families
* Actual home visiting services adhere to HFAK standards.
* HFAK promotes healthy family functioning, promotes child health and development, and prevents child abuse and neglect.
* Adherence to HFAK process standards is positively associated with achievement of outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Home Visitation Program to Promote Good Health and Development in Children at Risk for Abuse
NCT00218751
Assisting Low-Income Families at Pediatric Well-Child Care Visits
NCT00397644
Evaluation of a Home Visiting Program for First Time Parents
NCT00579449
A Computer-based Intervention to Augment Home Visitation Services: The E-Parenting Project
NCT01304719
Effectiveness of a Multi-Component Evidence-Based Parent Training Program in Reducing Child Maltreatment
NCT00595010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In 1998, the Alaska State Legislature requested a controlled study of HFAK to determine its effectiveness in preventing child maltreatment, promoting healthy family functioning, and promoting child health and development. DHSS awarded the Johns Hopkins University School of Medicine a contract to conduct the study from July 1999 through June 2004.
The study is a randomized trial of six HFAK sites throughout Alaska. It aims to compare services actually provided to HFAK standards, assess program success in achieving intended outcomes, and relate program impact to service delivery.
Families are enrolled over 21 months beginning in January 2000. Families are randomized to either the HFAk group or the control group. Baseline data on family attributes are collected from HFAK files and maternal interviews. HFAK service data are collected from the program's management information system, record reviews, surveys of staff, and staff focus groups. Outcome data are collected when the children were two years old through maternal interview, home-based observations, child developmental testing, review of medical records, and review of OCS child welfare records.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home Visited Mothers
Mothers randomized to the home visited group received AK State-funded home visiting services. Frequency of home visits was determined by home visiting staff based on mothers' needs. Mothers could receive home visiting services until their child turned 3 years old
Home Visiting
Control Mothers
Mothers randomized to the control group did not receive home visiting services, but were offered referrals to other community-based services, as was usual protocol with home visiting agencies were operating at capacity.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home Visiting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Family identified as at-risk by HFAK staff following the usual HFAK protocol
Exclusion Criteria
* Mother unable to speak English well enough to complete study activities.
* Family unwilling to enroll in the HFAK program.
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State of Alaska Department of Health and Social Services
UNKNOWN
Johns Hopkins University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne K Duggan, ScD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins University
Anchorage, Alaska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Contract Number 067727
Identifier Type: -
Identifier Source: secondary_id
99-0155
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.